glp-1/gip agonist Frontiers Mechanisms of action and therapeutic

Duckworth W, Abraira C, Moritz T et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes

Int J Endocrinol 2012

Coverage may expand, prescribing may standardize, and clinical frameworks may align

In some people, the blood sugar may get so low that they need another person to help them

Some of the inconsistency across preclinical reports reflects differences in the compounds, doses, and assay conditions used, so standardised reporting of peptide characterisation and experimental conditions would make the literature easier to interpret and to replicate

Bydureon: Summary of product characteristics